1146214-81-4

Basic information

• Product Name: 5-methoxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid methyl ester
• Synonyms: 5-methoxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid methyl ester
• CAS NO: 1146214-81-4
• Molecular Weight: 292.14
• Mol File: 1146214-81-4.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: 5-methoxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 5-methoxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid methyl ester(1146214-81-4)
• EPA Substance Registry System: 5-methoxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid methyl ester(1146214-81-4)

Safety Data

• Hazardous Substances Data: 1146214-81-4(Hazardous Substances Data)

Upstream product

• 5368-81-0 methyl 3-methoxybenzoate 
• 73183-34-3 bis(pinacol)diborane 
• 35450-36-3 methyl 2-bromo-5-methoxybenzoate 

Downstream Products

• 100009-76-5 1-(2'-methoxycarbonyl-4'-methoxyphenyl)-5,6,7-trimethoxyisoquinoline 
• 88741-65-5 methyl 2-(6,7-dimethoxyisoquinolin-1-yl)-5-methoxybenzoate 

Relevant articles and documents

COMPOUND HAVING BENZO SEVEN-MEMBERED RING STRUCTURE, PREPARATION METHOD THEREFOR, AND USE THEREOF

The present invention relates to a compound having a benzo seven-membered ring structure, and a preparation method therefor, and use thereof. The compound has a structure as represented by formula (I). Provided is use of the compound having the structure and prepared with the preparation method of the present invention, enantiomers, diastereomers, racemates and mixtures thereof of the compound, as well as chemically acceptable salts, crystalline hydrates and solvent mixtures of the compound and the enantiomers, diastereomers, racemates and mixtures thereof of the compound in the preparation of drugs for treating BET Bromodomain BRD4 activity or expression level related diseases.

INFLUENZA VIRUS REPLICATION INHIBITOR AND USE THEREOF

Disclosed are a compound as shown in formula (I) as an influenza virus replication inhibitor and a preparation method therefor, a pharmaceutical composition comprising the compound and the use of the compound and pharmaceutical composition thereof in the treatment of influenza.

FUSED PYRIDINES AS KINASE INHIBITORS

The present disclosure is generally directed to compounds which can inhibit AAK1 (adaptor associated kinase 1), compositions comprising such compounds, and methods for inhibiting AAK1.